Zhitong Finance App News, Xinnovo (300765.SZ) announced that the company's holding subsidiary Shiyao Group Jushi Biopharmaceutical Co., Ltd. (“Jushi Biotech”) recently received the “Notice of Acceptance” approved and issued by the State Drug Administration, and the marketing application for usinumab injections was accepted.

Zhitongcaijing · 5d ago
Zhitong Finance App News, Xinnovo (300765.SZ) announced that the company's holding subsidiary Shiyao Group Jushi Biopharmaceutical Co., Ltd. (“Jushi Biotech”) recently received the “Notice of Acceptance” approved and issued by the State Drug Administration, and the marketing application for usinumab injections was accepted.